FEATURED NEWS

• HDA Statement on President Trump's Announcement on the Opioid Crisis

  October 26, 2017

  Following President Trump’s announcement on the response to the opioid epidemic, Healthcare Distribution Alliance (HDA) President and CEO John M. Gray issued the following statement.

• What The Washington Post Won’t Say About Distributors and Regulation of Controlled Substances in the Supply Chain

  October 15, 2017

  The recent investigation by The Washington Post presented a misleading picture about the role of healthcare distributors in the pharmaceutical supply chain and the regulation of controlled substances and opioids in the market. Here are the facts and the information that The Post won’t share about the industry’s role and our members’ efforts to prevent diversion of controlled substances across the healthcare system.

• HDA Statement on 60 Minutes/Washington Post Coverage on Distributors, Opioid Epidemic

  October 13, 2017

  HDA President and CEO John M. Gray released the following statement in response to 60 Minutes/Washington Post coverage on the opioid epidemic.

• Giacomin, Smith Reelected to Lead HDA Board of Directors

  September 26, 2017

  The Healthcare Distribution Alliance (HDA) announced Jon Giacomin, Chief Executive Officer, Pharmaceutical segment, Cardinal Health, will serve a second term as Chairman of the HDA Board of Directors. Mr. Giacomin’s reelection was announced at the HDA Annual Board and Membership Meeting. Henry Dale Smith, Jr., Chairman and CEO, H. D. Smith Holding Company, also was reelected to serve as Vice Chairman.

• HDA Statement on Attorneys General Opioid Investigation

  September 19, 2017

  Following today’s announcement on investigations regarding the opioid epidemic, John M. Gray, President and CEO of the Healthcare Distribution Alliance (HDA), released the following statement.